Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Common Spine Disorders On CME Webcast

OSUWexnerbloglogo2014 Learn About Common Spine Disorders On CME Webcast. The most recent hurdle of impossibility was the application of minimally invasive techniques to spine surgery and these techniques now allow surgeons to repair the spine with less tissue disruption than ever before. Let’s welcome our guests today who are going to bring us up to date on new developments in spine surgery, Dr. Andrew Grossbach is Assistant Professor of Neurological Surgery and Dr. Stephanus Viljoen is also an Assistant Professor of Neurological Surgery, both from the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE what conditions can be treated with MIS spine surgery; and UNDERSTAND What to look for with cervical myelopathy.

You’ll also learn about the following:

  • Minimally invasive techniques in spine surgery
  • Cervical spondylotic myelopathy
  • Equipment used in minimally invasive spine surgery
  • Post-op recovery and long-term outcomes
  • Symptoms of Cervical Spondylotic myelopathy
  • Imaging strategies for cervical spine conditions
  • Imaging strategies for thoracic and lumbar spine conditions
  • Red flags on the CT or MRI report
  • Post-op recommendations after cervical spine surgery
  • Prevention of cervical spondylotic myelopathy

You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcasts Teaches on Cardiomyopathy

OSUWexnerbloglogo2014CME Webcasts Teaches on Cardiomyopathy. On this CME webcast, we are going to give you the information you need to be able to recognize cardiomyopathy in your patients and then to be able to identify the specific cause of their cardiomyopathy. Joining our moderator in the studio are two cardiologists from the Ohio State University. Dr. Sitaramesh Emani is an Assistant Professor of Internal Medicine and the Director of Heart Failure Clinical Trials at Ohio State. And Dr. Brent Lampert is an Assistant Professor of Internal Medicine and the Associate Program Director for the heart failure and transplant fellowship.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the common presenting signs and symptoms of cardiomyopathy; and REVIEW the diagnostic work up for cardiomyopathy.

You’ll also learn about the following:

  • Common causes of cardiomyopathy
  • Initial diagnostic steps in cardiomyopathy
  • Follow up imaging in patients with cardiomyopathy
  • Myocardial sarcoidosis
  • Physical examination of hypertrophic cardiomyopathy
  • Takotsubo cardiomyopathy
  • Diagnosing restrictive cardiomyopathies
  • Significance and work up of diastolic dysfunction
  • Chemotherapy-induced cardiomyopathy
  • Chagas Disease (Trypanosoma infection)

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Teaches Viewers About Acute Hepatitis

OSUWexnerbloglogo2014 CME Webcast Teaches Viewers About Acute Hepatitis. For his discovery of the virus we now know as hepatitis B and his discovery of a vaccine against it, Dr. Barry Blumberg was awarded the Nobel Prize. At the time of his death, the Scientific Director of the Fox Chase Cancer Center where Blumberg worked said of him: “I think it’s fair to say that Barry prevented more cancer deaths than any person who’s ever lived.” Hepatitis B is only one of a number of viruses as well as drugs and other conditions that can cause acute hepatitis. Here in the studio, with our moderator, to tell us about the different causes of acute hepatitis is hepatologist and Assistant Professor of Internal Medicine, Dr. Sean Kelly. And then to discuss the fundamentals of management of patients with acute liver failure, Associate Professor of Internal Medicine and the Director of the Section of Hepatology at the Ohio State University, Dr. James Hanje.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY the most common causes of acute hepatitis and characteristics of each type; and IDENTIFY the difference between abnormal liver function tests/acute hepatitis and Acute Liver Failure.

You’ll also learn about the following:

  • Common causes of acute hepatitis
  • New developments in the management of acute liver failure
  • Initial lab testing in patients with acute hepatitis
  • The role of radiographic imaging in evaluation of acute hepatitis
  • Use of the ammonia level in acute liver failure
  • When and how to assess intracranial hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.